Zum Hauptinhalt springen

Verschiedene

11. Dezember 2024 | Verschiedene

Freizeitkonsum von Distickstoffmonoxid in Europa: Situation, Risiken, Reaktionen

Freizeitkonsum von Distickstoffmonoxid in Europa: Situation, Risiken, Reaktionen In einigen Ländern Europas ist in letzter Zeit ein Anstieg des Freizeitkonsums von Distickstoffmonoxid zu beobachten. Diese Seite bietet eine Zusammenfassung der akt...

11. Dezember 2024 | Verschiedene

USA DEA – Drug Enforcement Administration: Factsheets über psycho-aktive Substanzen

USA DEA – Drug Enforcement Administration: Factsheets über psycho-aktive Substanzen https://www.dea.gov/factsheets

11. Dezember 2024 | Verschiedene

GLP-1s Hold Promise for Addiction but Questions Remain

GLP-1s Hold Promise for Addiction but Questions Remain Medscape - December 05, 2024. https://www.medscape.com/viewarticle/glp-1s-hold-promise-addiction-questions-remain-2024a1000mfj

10. Dezember 2024 | Verschiedene

Captagon: A comprehensive bibliometric analysis (1962-2024) of its global impact, health and mortality risks.

Captagon: A comprehensive bibliometric analysis (1962-2024) of its global impact, health and mortality risks. Fong S, Carollo A, Rossato A, Prevete E, Esposito G, Corazza O. Saudi Pharm J. 2024 Nov;32(11):102188. doi: 10.1016/j.jsps....

10. Dezember 2024 | Verschiedene

Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review.

Methylphenidate abuse and misuse in patients affected with a psychiatric disorder and a substance use disorder: a systematic review. Chiappini S, Gramuglia PD, Mosca A, Cavallotto C, Miuli A, Corkery JM, Guirguis A, Schifano F, Martinotti G...

04. Dezember 2024 | Verschiedene

Xylazine Pharmacokinetics in Patients Testing Positive for Fentanyl and Xylazine,

Xylazine Pharmacokinetics in Patients Testing Positive for Fentanyl and Xylazine, Yanchun Lin, Christopher W Farnsworth, Vahid Azimi, David B Liss, Michael E Mullins, Bridgit O Crews, Clinical Chemistry, 2024;, hvae163, doi.org/10.10...

04. Dezember 2024 | Verschiedene

Xylazine induces dopamine release and augments the effects of fentanyl.

Xylazine induces dopamine release and augments the effects of fentanyl. Trinko JR, Foscue E, Kong EM, Basu A, Corstens AM, Thompson SL, Kaye AP, Taylor JR, DiLeone RJ. J Clin Invest. 2024 Nov 15;134(22):e183354. doi: 10.1172/JCI18335...

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten